This overview highlights the impact of digital transformation on process development and regulatory readiness in biopharmaceutical organizations. While many teams continue to rely on legacy Electronic Lab Notebooks (ELNs), paper records, spreadsheets, and standalone software, these disconnected systems often create data silos, limit searchability, and make it difficult to effectively leverage valuable process knowledge. As a result, compiling information for regulatory submissions can become a major bottleneck. By adopting modern digital platforms such as IDBS Polar, organizations can reduce time spent on data administration, improve process understanding, and accelerate experimentation and decision-making. Digital transformation also enhances data accessibility, quality, compliance, and t

Join for free to read